Skip to main content
. 2012 Nov 14;35(12):2690–2697. doi: 10.2337/dc12-0312

Table 4.

Studies included in review: demographic data, vaccination schedule, and seroprotection (SP) proportion (anti-HBs cutoff of 10 mIU/mL)

graphic file with name 2690tbl4.jpg